Anke M. Kraft
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Particularly strong immune response to influenza vaccination in patients with decompensated liver cirrhosis linked to systemic inflammation.
Journal: Frontiers in immunology
Published: October 28, 2025
Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver Cirrhosis.
Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver Cirrhosis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 22, 2025
Unifying DNA methylation-based in silico cell-type deconvolution with deconvMe.
Journal: Bioinformatics advances
Published: April 30, 2025
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation.
Journal: Gut microbes
Published: April 21, 2025
T cell dysregulation reflects disease stage in hepatitis virus and alcohol-related liver disease.
Journal: Scientific reports
Published: March 31, 2025
Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapy.
Journal: Clinical and molecular hepatology
Published: March 20, 2025
HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV Coinfection.
Journal: Journal of viral hepatitis
Published: November 22, 2024
Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 30, 2024
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis.
Journal: Clinical and molecular hepatology
Published: July 22, 2024
Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infections.
Journal: Scientific reports
Published: July 16, 2024
MitoTempo treatment as an approach to cure persistent viral infections?
Journal: Virology
Published: June 25, 2024
Last Updated: 09/26/2026